Aerosol Medication Use in COVID-19 Pandemic
Asthma Allergy Immunology, cilt.18, sa.2, ss.110-112, 2020 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 18 Sayı: 2
- Basım Tarihi: 2020
- Doi Numarası: 10.21911/aai.539
- Dergi Adı: Asthma Allergy Immunology
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.110-112
- Anahtar Kelimeler: Aerosolized medications, bioaerosols, COVID-19
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Administration of aerolized drugs to patients diagnosed with COVID-19 leads to the risk of transmission of patient-generated infectious aerosols to healthcare providers.While the COVID-19 pandemic is ongoing, in order to provide the best treatment for patients and at the same time to protect healthcare providers at the highest level, it is necessary to increase access to information and pay maximum attention to preventive measures.